Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Trotti

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|January 15, 2003
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11Randal S Weber, Brian A Berkey, Arlene Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2016
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG ExperienceVoichita Bar-Ad, Qiang Ed Zhang, Paul M Harari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectantsMartee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Head & Neck|September 30, 2009
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.CDavid J Adelstein, John A Ridge, Maura L Gillison, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Practical Radiation Oncology|May 5, 2018
Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et alDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Cancer Medicine|September 4, 2018
Patient choice for high-volume center radiation impacts head and neck cancer outcomeArash O Naghavi, Michelle I Echevarria, Tobin J Strom, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Archives of Otolaryngology--Head & Neck Surgery|January 15, 2003
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11Randal S Weber, Brian A Berkey, Arlene Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2016
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG ExperienceVoichita Bar-Ad, Qiang Ed Zhang, Paul M Harari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectantsMartee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Head & Neck|September 30, 2009
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.CDavid J Adelstein, John A Ridge, Maura L Gillison, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Practical Radiation Oncology|May 5, 2018
Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et alDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Cancer Medicine|September 4, 2018
Patient choice for high-volume center radiation impacts head and neck cancer outcomeArash O Naghavi, Michelle I Echevarria, Tobin J Strom, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Pageof 7